CAR-T therapy in Sheba Hospital

Updated: November 2026

One of the largest CAR-T centers in Europe

Sheba Medical Center is one of the largest CAR-T centers in Europe, with more than 550 patients treated through its CAR-T programs, which began in 2016. Its teams combine specialist care with clinical research and the development of CAR-T treatments manufactured within the hospital.

A hospital ranked among the world’s best

Sheba Medical Center ranked seventh in Newsweek and Statista’s World’s Best Hospitals 2026, marking its eighth consecutive year in the world’s top ten.

Located in central Israel, Sheba brings together cancer care, specialist medical services and research facilities on one campus. Patients receiving CAR-T therapy benefit from an experienced treatment team within a comprehensive medical center, with other specialists available when needed.

Which diseases can be treated with CAR-T therapy?

Sheba’s CAR-T programs treat eligible patients with certain blood cancers, including some types of non-Hodgkin lymphoma, multiple myeloma and B-cell acute lymphoblastic leukemia (ALL). The appropriate treatment depends on the diagnosis, previous treatments, current medical condition and the requirements of the available program.

CAR-T is also offered through clinical trials for selected autoimmune diseases. Patients with autoimmune conditions can contact us to check whether their case may be suitable for specialist review. Read more about CAR-T therapy for autoimmune diseases.

How we can help you access CAR-T therapy at Sheba

Send us your medical documents in English or translated into English. We will forward them to Sheba’s specialist team for review and help you obtain information about suitability, timing and costs.

Our coordination and support come at no additional fee.

Time is precious. Let us help you move your research forward.